Matches in SemOpenAlex for { <https://semopenalex.org/work/W2154973129> ?p ?o ?g. }
- W2154973129 endingPage "657" @default.
- W2154973129 startingPage "648" @default.
- W2154973129 abstract "To evaluate the humoral immune response to pneumococcal and influenza vaccination in adults with rheumatoid arthritis (RA) receiving certolizumab pegol (CZP).In this 6-week, single-blind, placebo-controlled trial with optional 6-month open-label extension (NCT00993668), patients were stratified by concomitant methotrexate (MTX) use and randomized to receive CZP 400 mg (loading dose; according to CZP label) or placebo at weeks 0, 2, and 4. Pneumococcal (polysaccharide 23) and influenza vaccines were administered at Week 2. Satisfactory humoral immune response, defined as ≥2-fold titer increase in ≥3 of 6 pneumococcal antigens and ≥4-fold titer increase in ≥2 of 3 influenza antigens, were assessed independently 4 weeks after vaccination.Following pneumococcal vaccination, 62.5% of placebo patients and 54.5% of CZP patients without effective titers at baseline achieved a humoral response (difference in proportions was -8.0 percentage points; 95% CI -22.5 to 6.6%). Following influenza vaccination, 61.4% of placebo and 53.5% of CZP patients without effective titers at baseline achieved a humoral response (difference in proportions: -8.0 percentage points; 95% CI -22.9 to 7.0%). In all patients, including those with effective titers at baseline, 58.2% of placebo and 53.3% of CZP patients developed satisfactory pneumococcal titers, and 54.1% of placebo and 50.5% of CZP patients developed satisfactory influenza antibody titers. Vaccine responses to pneumococcal and influenza antigens were reduced similarly in both treatment groups with concomitant MTX use.Humoral immune responses to pneumococcal and influenza vaccination are not impaired when given during the loading phase of CZP treatment in patients with RA. (ClinicalTrials.gov NCT00993668)." @default.
- W2154973129 created "2016-06-24" @default.
- W2154973129 creator A5009369964 @default.
- W2154973129 creator A5017764759 @default.
- W2154973129 creator A5059168844 @default.
- W2154973129 creator A5066986646 @default.
- W2154973129 creator A5066995681 @default.
- W2154973129 creator A5082669130 @default.
- W2154973129 date "2014-03-01" @default.
- W2154973129 modified "2023-10-10" @default.
- W2154973129 title "Vaccine Responses in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol: Results from a Single-blind Randomized Phase IV Trial" @default.
- W2154973129 cites W1572018981 @default.
- W2154973129 cites W1969917809 @default.
- W2154973129 cites W2004868367 @default.
- W2154973129 cites W2006566716 @default.
- W2154973129 cites W2017419409 @default.
- W2154973129 cites W2019830518 @default.
- W2154973129 cites W2026732514 @default.
- W2154973129 cites W2027502756 @default.
- W2154973129 cites W2038684305 @default.
- W2154973129 cites W2039439001 @default.
- W2154973129 cites W2042927558 @default.
- W2154973129 cites W2059903231 @default.
- W2154973129 cites W2068119026 @default.
- W2154973129 cites W2085947993 @default.
- W2154973129 cites W2088235366 @default.
- W2154973129 cites W2092395516 @default.
- W2154973129 cites W2099199787 @default.
- W2154973129 cites W2102990989 @default.
- W2154973129 cites W2125169255 @default.
- W2154973129 cites W2125501404 @default.
- W2154973129 cites W2132324777 @default.
- W2154973129 cites W2134009713 @default.
- W2154973129 cites W2140724620 @default.
- W2154973129 cites W2148069290 @default.
- W2154973129 cites W2152348310 @default.
- W2154973129 cites W2160512516 @default.
- W2154973129 cites W2163817180 @default.
- W2154973129 cites W2165601272 @default.
- W2154973129 cites W2167795826 @default.
- W2154973129 cites W2168370388 @default.
- W2154973129 cites W2170155793 @default.
- W2154973129 cites W2171443992 @default.
- W2154973129 cites W2337711227 @default.
- W2154973129 doi "https://doi.org/10.3899/jrheum.130945" @default.
- W2154973129 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24584918" @default.
- W2154973129 hasPublicationYear "2014" @default.
- W2154973129 type Work @default.
- W2154973129 sameAs 2154973129 @default.
- W2154973129 citedByCount "64" @default.
- W2154973129 countsByYear W21549731292014 @default.
- W2154973129 countsByYear W21549731292015 @default.
- W2154973129 countsByYear W21549731292016 @default.
- W2154973129 countsByYear W21549731292017 @default.
- W2154973129 countsByYear W21549731292018 @default.
- W2154973129 countsByYear W21549731292019 @default.
- W2154973129 countsByYear W21549731292020 @default.
- W2154973129 countsByYear W21549731292021 @default.
- W2154973129 countsByYear W21549731292022 @default.
- W2154973129 countsByYear W21549731292023 @default.
- W2154973129 crossrefType "journal-article" @default.
- W2154973129 hasAuthorship W2154973129A5009369964 @default.
- W2154973129 hasAuthorship W2154973129A5017764759 @default.
- W2154973129 hasAuthorship W2154973129A5059168844 @default.
- W2154973129 hasAuthorship W2154973129A5066986646 @default.
- W2154973129 hasAuthorship W2154973129A5066995681 @default.
- W2154973129 hasAuthorship W2154973129A5082669130 @default.
- W2154973129 hasBestOaLocation W21549731291 @default.
- W2154973129 hasConcept C126322002 @default.
- W2154973129 hasConcept C142724271 @default.
- W2154973129 hasConcept C159654299 @default.
- W2154973129 hasConcept C203014093 @default.
- W2154973129 hasConcept C204787440 @default.
- W2154973129 hasConcept C22070199 @default.
- W2154973129 hasConcept C22889606 @default.
- W2154973129 hasConcept C27081682 @default.
- W2154973129 hasConcept C2776215756 @default.
- W2154973129 hasConcept C2777575956 @default.
- W2154973129 hasConcept C2778866548 @default.
- W2154973129 hasConcept C2779301066 @default.
- W2154973129 hasConcept C2779384505 @default.
- W2154973129 hasConcept C2779664119 @default.
- W2154973129 hasConcept C2780132546 @default.
- W2154973129 hasConcept C2780689484 @default.
- W2154973129 hasConcept C2781253189 @default.
- W2154973129 hasConcept C3020803494 @default.
- W2154973129 hasConcept C32611913 @default.
- W2154973129 hasConcept C501593827 @default.
- W2154973129 hasConcept C71924100 @default.
- W2154973129 hasConcept C86803240 @default.
- W2154973129 hasConcept C89423630 @default.
- W2154973129 hasConcept C90924648 @default.
- W2154973129 hasConceptScore W2154973129C126322002 @default.
- W2154973129 hasConceptScore W2154973129C142724271 @default.
- W2154973129 hasConceptScore W2154973129C159654299 @default.
- W2154973129 hasConceptScore W2154973129C203014093 @default.
- W2154973129 hasConceptScore W2154973129C204787440 @default.
- W2154973129 hasConceptScore W2154973129C22070199 @default.